INTRODUCTION AND OBJECTIVES: Several definitions of high-risk prostate cancer (PCa) exist. We examined the impact of different pre-treatment definitions on metastasis-free survival (MFS), cancer-specific mortality (CSM) and overall mortality (OM) after radical prostatectomy (RP) RESULTS: Depending on the definition, patients with high-risk PCa comprised between 0.9% (when using cT3 as the criterion) and 20.4% (when using the D'Amico criterion) of the population. Median follow-up was 60.9 months. 10-year metastasis-free survival rates ranged from 78.9% (PSA !20 ng/ml) to 66.5% (Gleason 8-10). 10-year cancer-specific survival rates varied from 94.6 (PSA !20 ng/ml) to 86.6% (cT3). 10-year overall survival rates ranged from 87.1 (NCCN high risk) to 79.3% (!cT2c). On multivariable analysis, all high-risk definitions were associated with a higher risk of metastasis compared to lower risk groups (hazard ratio [HR] between 3.3 for !cT2c and 9.5 for Gleason 8-10; all p < 0.001). All high-risk definitions were associated with a higher risk of CSM compared to lower risk groups (HR between 3.4 for PSA !20 ng/ml and 6.4 for cT3; all p < 0.001). All definitions of high risk were associated with a higher risk of OM (HR between 2.0 for PSA !20 ng/ml to 2.4 for !cT2c; all p < 0.01).
CONCLUSIONS: Variety in outcomes exist, depending on the pre-treatment definition of high-risk PC. Among the tested, Gleason 8-10 was the strongest predictor for higher risk of metastasis, cT3 was the strongest predictor for higher risk of CSM and OM.
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PD40-03 EFFECT OF PERSONALIZED EXTRACORPOREAL BIOFEEDBACK DEVICE FOR PELVIC FLOOR MUSCLE TRAINING ON URINARY INCONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RANDOMIZED CONTROLLED TRIAL
Jung Kwon Kim*, Jong Jin Oh, Hakmin Lee, Sangchul Lee, Sung Kyu Hong, Sang Eun Lee, Seok-Soo Byun, Seongnam-si, Korea, Republic of INTRODUCTION AND OBJECTIVES: The effect of biofeedback for pelvic floor muscle training (PFMT) on the recovery of postprostatectomy urinary incontinence (PPI) is still controversial. We performed a randomized controlled trial to investigate the effectiveness of a novel personalized extracorporeal biofeedback device (Anykegelä) for PFMT on PPI after robot-assisted laparoscopic radical prostatectomy (RARP).
METHODS: A total of 84 patients who underwent RARP were randomized either to the intervention group (42) (receiving biofeedback-PFMT using a novel device [Anykegelä] in addition to verbal and written instruction) or the control group (42). Patients were evaluated 1, 2, and 3 months after surgery. Incontinence severity was measured by the 24-h pad test. The International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF-5) questionnaire were also assessed.
RESULTS: Regarding the average urine loss in the 24-h pad test, the intervention group showed significantly smaller volume of urine loss at the 1 month follow-up than the control group (71.0g vs. 120.8g, respectively, p [ 0.028). However, from the 2 month follow-up visit, no significant differences were observed between the two groups. In addition, in the 1 month follow-up data of the IPSS-total score, the intervention group demonstrated significantly favorable changes from baseline with improved scores compared to the control group (0.25 AE 9.15 vs. -3.81 AE 8.98, respectively, p [ 0.046).
CONCLUSIONS: The personalized extracorporeal biofeedback device (Anykegelä) for PFMT offers a significant positive effect on the
